WO2010079506A3 - Pharmaceutical composition of aripiprazole - Google Patents
Pharmaceutical composition of aripiprazole Download PDFInfo
- Publication number
- WO2010079506A3 WO2010079506A3 PCT/IN2009/000356 IN2009000356W WO2010079506A3 WO 2010079506 A3 WO2010079506 A3 WO 2010079506A3 IN 2009000356 W IN2009000356 W IN 2009000356W WO 2010079506 A3 WO2010079506 A3 WO 2010079506A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- aripiprazole
- pharmaceutical composition
- present
- solid oral
- oral pharmaceutical
- Prior art date
Links
- CEUORZQYGODEFX-UHFFFAOYSA-N Aripirazole Chemical compound ClC1=CC=CC(N2CCN(CCCCOC=3C=C4NC(=O)CCC4=CC=3)CC2)=C1Cl CEUORZQYGODEFX-UHFFFAOYSA-N 0.000 title abstract 3
- 229960004372 aripiprazole Drugs 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000008203 oral pharmaceutical composition Substances 0.000 abstract 2
- 239000007787 solid Substances 0.000 abstract 2
- 239000003085 diluting agent Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000005550 wet granulation Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to stable, solid oral pharmaceutical composition comprising aripiprazole manufactured by wet granulation, wherein intragranular stage is devoid of diluent. The present invention further relates to processes for the preparation of said solid oral pharmaceutical composition of aripiprazole.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1302/MUM/2008 | 2008-06-23 | ||
IN1302MU2008 | 2008-06-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010079506A2 WO2010079506A2 (en) | 2010-07-15 |
WO2010079506A3 true WO2010079506A3 (en) | 2010-09-10 |
Family
ID=42272511
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2009/000356 WO2010079506A2 (en) | 2008-06-23 | 2009-06-22 | Pharmaceutical composition of aripiprazole |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2010079506A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR201000948A1 (en) * | 2010-02-09 | 2011-08-22 | Sanovel İlaç San.Ve Ti̇c.A.Ş. | Aripiprazole formulations. |
WO2014104989A1 (en) * | 2011-12-27 | 2014-07-03 | Mahmut Bilgic | Pharmaceutical compositions comprising aripiprazole |
WO2013100878A1 (en) * | 2011-12-27 | 2013-07-04 | Mahmut Bilgic | Pharmaceutical formulations comprising aripiprazole |
TW201343201A (en) * | 2012-03-06 | 2013-11-01 | Otsuka Pharma Co Ltd | Sustained release oral solid preparation |
WO2013175508A2 (en) * | 2012-05-24 | 2013-11-28 | Medreich Limited | Stable pharmaceutical composition of aripiprazole |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060257471A1 (en) * | 2005-03-17 | 2006-11-16 | Ettema Gerrit J | Pharmaceutical tablets of crystalline Type II aripiprazole |
WO2007081367A1 (en) * | 2006-01-05 | 2007-07-19 | Teva Pharmaceutical Industries Ltd. | Dry formulations of aripiprazole |
WO2007081366A1 (en) * | 2006-01-05 | 2007-07-19 | Teva Pharmaceutical Industries Ltd. | Wet granulation pharmaceutical compositions of aripiprazole |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5006528A (en) | 1988-10-31 | 1991-04-09 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
AR033485A1 (en) | 2001-09-25 | 2003-12-26 | Otsuka Pharma Co Ltd | MEDICINAL SUBSTANCE OF ARIPIPRAZOL OF LOW HYGROSCOPICITY AND PROCESS FOR THE PREPARATION OF THE SAME |
-
2009
- 2009-06-22 WO PCT/IN2009/000356 patent/WO2010079506A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060257471A1 (en) * | 2005-03-17 | 2006-11-16 | Ettema Gerrit J | Pharmaceutical tablets of crystalline Type II aripiprazole |
WO2007081367A1 (en) * | 2006-01-05 | 2007-07-19 | Teva Pharmaceutical Industries Ltd. | Dry formulations of aripiprazole |
WO2007081366A1 (en) * | 2006-01-05 | 2007-07-19 | Teva Pharmaceutical Industries Ltd. | Wet granulation pharmaceutical compositions of aripiprazole |
Non-Patent Citations (1)
Title |
---|
AOKI S ET AL: "Study on Crystal Transformation of ARIPIPRAZOL", 19961006, 6 October 1996 (1996-10-06), pages 937 - 940, XP002970982 * |
Also Published As
Publication number | Publication date |
---|---|
WO2010079506A2 (en) | 2010-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010092090A3 (en) | Novel salts of sitagliptin | |
WO2010049454A3 (en) | Antimicrobial composition from copepods | |
WO2009085990A3 (en) | Processes for the preparation of sitagliptin and pharmaceutically acceptable salts thereof | |
WO2008127646A3 (en) | Transaminase-based processes for preparation of pregabalin | |
WO2009104021A3 (en) | Novel polymorphs and processes for their preparation | |
WO2008149345A3 (en) | Tri-aryl compounds and compositions comprising the same | |
WO2011012816A3 (en) | Pharmaceutical formulation | |
WO2010117738A3 (en) | Solid state forms of sitagliptin salts | |
GEP20156328B (en) | Solid pharmaceutical compositions and processes for their production | |
WO2010139981A3 (en) | Processes for preparing crystalline forms of dasatinib | |
WO2012025944A3 (en) | Sitagliptin, salts and polymorphs thereof | |
WO2012070062A3 (en) | Novel polymorph of nilotinib hydrochloride | |
WO2010049449A3 (en) | Novel salts of sunitinib | |
WO2009094457A3 (en) | Substituted benzhydrylethers | |
CL2007003875A1 (en) | COMPOUNDS DERIVED FROM AMIDAS OF THE 3-AMINO TETRAHYDROFURAN-3-CARBOXYL ACID; PROCEDURE FOR PREPARATION OF SUCH COMPOUNDS. | |
WO2008129501A3 (en) | Pharmaceutical compositions of duloxetine | |
EP2666765A3 (en) | Process for the preparation of substituted 3-(1-amino-2-methyl-pentane-3-yl)phenyl compounds | |
WO2012137227A3 (en) | Solid forms of antiretroviral compounds and anti-oxidative acids, processes for preparation and pharmaceutical compositions thereof | |
WO2010079506A3 (en) | Pharmaceutical composition of aripiprazole | |
WO2007098273A3 (en) | Novel crystalline forms of armodafinil and preparation thereof | |
WO2012075015A3 (en) | Oral metronidazole pharmaceutical compositions | |
WO2008073863A3 (en) | Preparation and utility of substituted allylamines | |
WO2010079045A3 (en) | Crystalline salt forms of flibanserine | |
WO2011069032A3 (en) | Formulations, salts and polymorphs of transnorsertraline and uses thereof | |
WO2010015656A3 (en) | Alkoxypyrazoles and the process for their preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09828418 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09828418 Country of ref document: EP Kind code of ref document: A2 |